Back
BridgeBio Pharma Inc (BBIO)
BiotechnologyBBIO · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$80.42
−0.81%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$-3.79
ROE
Gross margin
95.1%
Debt/Equity
Revenue growth
66.8%
P/B ratio
Beta
Forward P/E
BridgeBio Pharma Inc — company intelligence
Earnings surprises
Q2 2026$-0.78 vs $-0.60 est-31.1%
Q1 2026$-0.84 vs $-0.69 est-21.4%
Q4 2025$-1.00 vs $-0.76 est-32.1%
Q3 2025$-0.95 vs $-0.91 est-4.8%
Analyst consensus · 28 analysts
25 Buy3 Hold0 Sell
Updated Aug 23, 2026
Insider activity · 90 days
24 buys15 sellsnet -20,873 shares
Apuli MaricelSell 2,000 · Jul 30, 2026
Ellis Andreaother 17,167 · Jul 9, 2026
Cook Jennifer E.other 17,167 · Jul 9, 2026
Recent SEC filings
4 — Insider transaction reportAug 20, 2026
4 — Insider transaction reportAug 18, 2026
4 — Insider transaction reportAug 18, 2026
Latest news
BridgeBio Pharma Launches Secondary Public Offering Of 5M Shares Of Common Stock By Selling Stockholder KKR Genetic Disorder L.P — Benzinga · 1w ago
Truist Securities Maintains Buy on BridgeBio Pharma, Raises Price Target to $107 — Benzinga · 1w ago
Canaccord Genuity Maintains Buy on BridgeBio Pharma, Raises Price Target to $106 — Benzinga · 1w ago
JP Morgan Maintains Overweight on BridgeBio Pharma, Raises Price Target to $111 — Benzinga · 1w ago
BridgeBio: Attruby Delivers In Q2, Expect Three New Launches In 12 Months — SeekingAlpha · 2w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.